
After years of discouragement, more kidney patients are having healthy babies
Care innovations have allowed many more people with kidney disease to become parents. But pregnancy still carries risks
Cassandra Willyard is a journalist who covers health and science with a focus on infectious disease, public health and drug development. Her work has appeared in the Atlantic, Nature and the New York Times.

After years of discouragement, more kidney patients are having healthy babies
Care innovations have allowed many more people with kidney disease to become parents. But pregnancy still carries risks

Lab-Made Mini Organs Could Transform Female Reproductive Medicine
Artificial tissues that mimic the placenta, endometrium, ovary and vagina could point to treatments for common conditions such as preeclampsia and endometriosis

The Vexing Promise of New Blood Tests for Alzheimer’s
A new generation of Alzheimer’s blood tests could speed up diagnosis and access to care—but they also raise thorny questions about prediction, treatment and uncertainty

Removing Bias from Devices and Diagnostics Can Save Lives
New formulas, devices and tools are removing historical bias from medical diagnoses

This New Antivenom Defangs the Toxins of Cobras, Black Mambas and More
A synthetic antibody marks a big step toward antivenoms that can protect against every venomous snake near where you live or travel

More People Die from Venomous Snakebites Each Year Than Have Ever Died from Ebola
In low- and middle-income nations, snakebite envenoming is more deadly than almost any other neglected tropical disease

Mouse Embryos Grown without Eggs or Sperm
Two research teams grew synthetic embryos using stem cells for long enough to see some organs develop

Are ‘COVID Toes’ Actually Caused by the Coronavirus?
A study adds to evidence suggesting that SARS-CoV-2 infection doesn’t cause an inflamed-toe condition called chilblains, but it doesn’t close the door

The Colon Cancer Conundrum
Colorectal cancer rates in younger adults are climbing. The race is on to figure out why

How Antiviral Pill Molnupiravir Shot Ahead in the COVID Drug Hunt
The Merck pill, which could become the first oral antiviral COVID treatment, forces the coronavirus SARS-CoV-2 to mutate itself to death

Blood Clots Are Mysteriously Tied to Many Coronavirus Problems
Research begins to pick apart the mechanisms behind a deadly COVID-19 complication

Can AI Fix Electronic Medical Records?
Digitization of patient charts was supposed to revolutionize medical practice. Artificial intelligence could help unlock its potential

How a Revolutionary Technique Got People with Spinal-Cord Injuries Back on Their Feet
Electrical stimulation has promised huge gains for people with paralysis. Now comes the hard part—getting beyond those first steps

New Human Gene Tally Reignites Debate
The controversy over how many genes are contained in the human genome continues to simmer

Squeaky Clean Mice Could Be Ruining Research
Pristine lab conditions may not provide the best model for human disease

Cancer Therapy: An Evolved Approach
Tumours are subject to the same rules of natural selection as any other living thing. Clinicians are now putting that knowledge to use

Biotech Interest in Mini Organs Booms
Biologists are building banks of ‘organoids’, and learning a lot about human development on the way

Time for a ‘Completely Different’ Haemophilia Treatment?
A promising therapy curtails clotting inhibitors rather than replacing proteins that promote blood clotting

How Do Tumors Grow?
An alternative explanation for cancer's origins could lead to better therapies

Drastic Measures: 8 Wild Ways to Combat Invasive Species
Employing everything from love potion to meat-eating ants, scientists try to stem the influx of new invasive species with some "creative" ideas